Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis.
European archives of psychiatry and clinical neuroscience · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMajor Depressive DisorderMaleFemaleEndocannabinoidsSex CharacteristicsPolymorphism, Single NucleotideTreatment Effect HeterogeneityAdultMiddle AgedAntidepressive AgentsDNA MethylationBiomarkersRNA, MessengerEscitalopramOutcome Assessment, Health CareEndocannabinoid systemMajor depressive disorderMethylation expressionSex differencesmRNA expression
Come citare questo studio
Maryam Sorkhou, Helena K Kim, Faranak Farzan, Jane A Foster, Benicio N Frey, Muhammad I Husain, Sidney H Kennedy, Raymond W Lam, Roumen Milev, Benoit H Mulsant, Daniel J Müller, Lena C Quilty, Claudio N Soares, Valerie H Taylor, Gustavo Turecki, Stefan Kloiber. (2026). Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis.. European archives of psychiatry and clinical neuroscience. DOI: 10.1007/s00406-026-02362-3
Consulta la pubblicazione originale ↗